All material subject to strictly enforced copyright laws. © 2022 Managing IP is part of the Euromoney Institutional Investor PLC group.

Roche loses patent opposition in India

In another blow to multinational pharmaceutical companies in India, the Chennai Patent Office has invalidated a key patent owned by Swiss drug maker F Hoffmann La Roche, allowing generic competitors to enter the market

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
more from across site and ros bottom lb

More from across our site

Simon Malynicz tells Managing IP why he went back to Hogarth Chambers from Three New Square
Sources at five litigation funders explain how they identify new IP business and how counsel can help
Lawyers at Pinsent Masons explore strategic opportunities at the UPC for patentees and potential defendants
The claim filed at the England and Wales High Court follows lawsuits launched by Moderna in the US and Germany
Litigation funders set out what they look for in cases and how external lawyers can get their attention
The NIST director and register of copyrights were added as co-vice chairs of the Council for Inclusive Innovation, among others
Unnat Pandit, the newly appointed head of the Indian IP office, is working on bridging communication gaps and using tech to resolve administrative holdups
Erso Capital said the decision to create a pool specifically for patent litigation was based on rising demand in the tech and life sciences sectors
Firms and companies are invited to participate in the research for the 2023 edition of Managing IP Awards and IP STARS rankings
Counsel at Gemini, a fintech company and two firms say they have to be more thoughtful about patent filing and NPE litigation
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree